To assess the possible effects of lipid metabolism on insulin-mediated glucose disposal, 18 nondiabetic Pima Indian women (age 18-35 yr) were studied using 1-14C-palmitate infusion to measure free fatty acid turnover rate followed by a euglycemic clamp (clamp) to measure in vivo insulin-mediated glucose disposal (M). Indirect calorimetry was performed in the basal state and during the clamp. This was used to assess glucose oxidation rate, lipid oxidation rate, and to calculate nonoxidative glucose disposal (storage). Basal and clamp lipid oxidation rate correlated with basal plasma free fatty acid concentration (r = 0.81, P less than or equal to 0.0001, r = 0.67, P less than 0.003, respectively). The fall in lipid oxidation was highly correlated with the increase in glucose oxidation during the insulin infusion (r = 0.96, P less than or equal to 0.0001). The clamp lipid oxidation rate negatively correlated with the glucose oxidation rate (r = -0.85, P less than 0.0001) and with the M value (r = -0.60, P less than 0.01) but was not correlated with the clamp glucose storage (r = -0.2, P = 0.4). On the other hand, glucose storage appeared to make a greater contribution to the difference in M value between the upper and lower extremes of M than did glucose oxidation, as evidenced by an increase in glucose storage […] 
20 yr ago, Randle et al. (1) proposed a glucose fatty acid cycle, wherein an increased availability of fatty acids and ketone bodies for oxidation might be responsible for alterations of carbohydrate metabolism in muscle, in diabetes mellitus, starvation, and carbohydrate deprivation. Aspects of this proposed biochemical syndrome included impaired in vivo insulin action and impaired glucose tolerance. This concept was extended with the suggestion that one distinct role of insulin was to control glucose uptake via variations in the rate of fatty acid mobilization from adipose tissue (2, 3) . Recently, the important role of ketones-intermediate metabolic products of free fatty acids (FFAs)'-in regulating key sites of the glucose oxidative pathway has been emphasized (3, 4) and the initial Randle hypothesis has been extended to a glucose fatty acid ketone body cycle (3) .
The physiological basis for the proposal of Randle and coworkers has been the subject of a number of reviews and discussions (1) (2) (3) (4) (5) (6) (7) (8) . Fatty acids or ketones inhibit glucose oxidation and uptake in perfused rat heart, or diaphragm by regulating key enzymes, viz pyruvate dehydrogenase and phosphofructokinase. The accumulation of glucose-6-phosphate from the latter inhibition in turn inhibits hexokinase. The presence of an inhibition of carbohydrate metabolism by fatty acids or ketones in skeletal muscle has been more controversial, but recent views favor this interaction (4, 9-1 1). Inhibition of glucose oxidation by ketones has also been demonstrated in brain, kidney, and small intestine (4) . Consistent with these in vitro studies are the findings of a number of in vivo studies. Infusions of nicotinic acid or related compounds are accompanied by a fall in plasma FFAs and an increase in whole body glucose oxidation as measured by labeled CO2 production or by indirect calorimetry (12) (13) (14) . Elevations of plasma FFAs with lipid/heparin infusions decrease glucose oxidation assessed by the same techniques. (14) (15) (16) (17) (18) . Changes in glucose tolerance have been demonstrated with experimental elevations of FFAs (14, (18) (19) (20) (21) but not in all studies (22) . Glucose disposal during a euglycemic clamp (clamp) falls during lipid/heparin infusions (7, 17) . It remains a critical question, however, whether the reduced insulin- 1 . Abbreviations used in this paper: Ra, appearance rate; BMI, body mass index; CV, coefficient of variation; EGPR, endogenous glucose production rate; clamp, euglycemic clamp; FFM, fat-free mass; FFA, free fatty acid(s)/plasma FFA concentration; M, glucose disposal during hyperinsulinemia (used synonymously with insulin-mediated glucose disposal-see calculations in Methods); storage, nonoxidative glucose disposal; RQ, respiratory quotient; RQL, respiratory quotient for lipid oxidation-may vary depending on the particular lipid; excess C02, total CO2 produced minus total 02 consumed; VCO2, carbon dioxide production; V02, oxygen consumption. mediated glucose disposal (M) found in many obese subjects is in fact related to changes in endogenous lipid metabolism.
This study combines the techniques of the clamp, indirect calorimetry, and labeled FFA infusion, allowing an examination of the relationships between insulin-mediated glucose disposal, carbohydrate oxidation and storage, and measures of lipid metabolism including FFA turnover and lipid oxidation. Subjects studied had a wide range of obesity, thus providing a range of lipid metabolic profiles and hence specifically avoiding the need to experimentally alter FFA metabolism.
Methods
Study subjects. 18 Southwest American Indian (Pima) women were selected to cover a wide range of obesity. All were studied in the Phoenix Clinical Research Section, after being stabilized for five or more days on a weight maintenance diet (45% carbohydrate, 40% fat, 15% protein). All subjects were in good health as assessed with a medical history, physical examination, and routine hematological, biochemical, and urine tests. None were diabetic or had impaired glucose tolerance (23). Body composition was determined by underwater weighing (24) with simultaneous determination of residual lung volume.
Calculation of percent fat was according to Keys and Brozek (25) .
These results were used to calculate fat mass and fat-free mass (FFM). All subjects gave informed consent and the studies were approved by the ethical committees of the National Institutes of Health and Indian Health Service, and by the Gila River Indian Community. Clinical data for the subjects are shown on Table I .
Experimental protocol. After at least 5 d on a standard diet and after an overnight fast of 13-14 h, measurement of FFA turnover was performed with simultaneous indirect calorimetry, followed by a clamp with simultaneous indirect calorimetry.
FFA turnover studies were performed using methods developed by Havel et al. (26) . I-'4C-palmitate (New England Nuclear, Boston, MA) was complexed to fatty acid poor human serum albumin (Sigma Chemical Co., St. Louis, MO) under sterile conditions. The labeled palmitate was evaporated to dryness, dissolved in 0.02 M NaOH, and added dropwise to the stirring warmed albumin solution. The final preparation (10 mg/ml albumin, 0.5 ACi '4C/ml, 2.3 mg palmitate/ ml) was infused at a rate of 0.5 ml/min. 66 min before the start of the insulin infusion, a plasma sample was obtained for baseline FFA concentration, and 14C-palmitate infusion commenced. Beginning 35 min after the 14C-palmitate infusion commenced, four blood samples were drawn over 23 min for determination of FFA concentration and specific activity. These sampling times overlapped in part the sampling times for the preinsulin [3-3H] glucose. Previous reports suggested the FFA specific activity would be at a steady state at the time of blood collection in the above protocol (26, 27) . In this study, the mean of the coefficients of variation (CV), calculated for each individual, of FFA specific activity was 7.3%. Specific activity showed no significant change over the study period (change = +4.1±2.5%) (P = 0.1 1).
The clamp was performed by a modification of the method of DeFronzo et al. (28) . At 0600 h and after the patient had voided an intravenous catheter was placed in an antecubital vein for infusion of insulin, glucose, [3-3H] glucose, and 1-_4C-palmitate. Another catheter was placed retrograde in a dorsal vein of the contralateral hand for blood withdrawal. The hand was kept in a warming box at 70'C. A primed, continuous infusion of [3-3H] glucose was then begun and continued throughout the procedure. After 2.5 h, four plasma samples were obtained during a 30-min period for [3-3H] glucose specific activity determinations. After 3 h, primed continuous infusion of purified pork insulin (Velosulin; Nordisk-USA, Bethesda, MD) (40 mU/m2 per min) was started. 5 min after the start of the insulin, a variable 20% glucose infusion was started to maintain the plasma glucose concentration at approximately the basal glucose level for the entire 100 min of hyperinsulinemia. Samples for plasma glucose concentration were obtained every 5 min throughout the test. Samples for plasma insulin and [3-3Hjglucose specific activity were obtained every 10 min from 60 to 100 min. Glucose and insulin levels during the clamp were: mean (±SE) glucose 93.1±1.2 mg/dl (mean CV 2.5±0.1%), and mean insulin 128±10 MU/ml (mean CV 4.1±0.6%).
During the 1-'4C-palmitate infusion and throughout the insulin infusions, oxygen consumption and carbon dioxide production were determined by open circuit indirect calorimetry (14, 29) . A transparent plastic hood was placed over the subject's head and secured around the neck with a soft collar. Room air was drawn through the hood at a rate of 25-40 liter/min. The flow rate was measured using a pneumotachograph attached to a Fleisch flow transducer (Gould Electronics & Electrical Products, Cleveland, OH). A constant fraction of the expired gases was withdrawn and analyzed for oxygen and CO2 concentrations. The oxygen was measured on a zirconium cell analyzer and the CO2 on an infrared analyzer (both from Applied Electrochemistry, Sunnyvale, CA). The analyzers and flow meter outputs were connected to a desk top computer (Hewlett Packard Co., Palo Alto, CA), which recorded continuous integrated calorimetric measurements over 5-min intervals. Nonprotein oxidation during the test was estimated using the urinary urea production rate. This was calculated as the urine urea concentration times urine volume times time since last voiding, on a specimen collected at the end of the clamp. The nonprotein respiratory quotient was then calculated and substrate oxidation values determined from the equations of Lusk (30) .
Analytical methods. Plasma glucose concentration was measured by the glucose oxidase method using a Beckman glucose analyzer (Beckman Instruments Inc., Fullerton, CA). Plasma insulin concentrations were determined by the Herbert modification (31) of the radioimmunoassay of Yalow and Berson (32). The tritiated glucose specific activity in blood samples was measured as described previously by others (33) using perchloric acid to precipitate plasma proteins. FFAs were measured by a modification of the method of Soloni and Sardina (34) as described previously (35) . The FFA assay was standardized by the inclusion of reference pools that were calibrated using the titration method of Dole (36) as modified by Trout et al. (37). All samples for fatty acid determination were collected in tubes containing paraoxon (1.1 mg/2 ml) and kept on ice at all times. FFA concentration and radioactivity were determined after the plasma was extracted with 10 ml isopropanol/heptane/H2SO4 (ratio 40:10:1), 6 ml heptane and 4 ml H20 were added, and fatty acids were isolated from the lipid extract using 0.02 N NaOH and reextracted using acidified heptane.
Calculations. Substrate oxidation rates were calculated according to published methods (14, 29, 30, 38, 39) (for exceptions see Appendix). The following constants were used: 6.25 g of protein were oxidized to produce I g of urea nitrogen, and 966.3 ml of 02 were required to oxidize I g of protein in this way, producing 773.9 ml of CO2. The respiratory quotient (RQ) for oxidation of lipid is 0.707 and for carbohydrate 1.000. Oxygen consumed is 2019.3 ml/g of fat, 828.8 ml/g of glycogen, and 745.8 ml/g of glucose. The constants for glycogen were used for calculations in the basal state. During the clamp, the constants for glucose were used. It should be noted that the constants used for lipid oxidation were those for the consumption of whole fat. Since this contained glycerol, the fatty acid oxidation (in milligrams) was overestimated. The difference would, however, be <4% if pure palmitate (RQ = 0.696) and <1% if pure oleate (RQ = 0.706) were assumed to be oxidized. Lipid oxidation in milligrams was converted to moles using the molecular weight of palmitic acid, so that the data for turnover and oxidation could be compared directly.
The basal and insulin stimulated carbohydrate oxidation rates and lipid oxidation were calculated from the indirect calorimetric data by averaging the data for 40 min before the beginning of the insulin infusion and for the last 40 min during the insulin infusion. The carbohydrate storage rate was estimated by subtracting the carbohydrate oxidation rate from the total glucose disposal rate (see below) during the insulin infusions. negative value. Since lipid synthesis produces more CO2 than oxygen consumed on a molar basis, it was assumed that an RQ > 1.00 implies net lipid synthesis. The amount of lipid synthesized from glucose for an RQ > 1.000 was taken as the absolute value of the lipid oxidation as suggested by Frayn (39) (see Appendix). The amount of glucose this represents can be calculated using the constants already noted, and this was included in the value for nonoxidized or stored glucose. In those two subjects where the RQ exceeded 1.000 during the insulin infusion, oxidation of glucose was calculated as the glucose oxidation rate by the equations of Lusk (30), less the glucose assumed to be going into lipid synthesis (see Appendix). Storage was then calculated as above.
The appearance rate (Ra) of glucose in the plasma was calculated from the plasma[3-3H]glucose specific activities using the equations of Steele (40) . In the resting, postabsorptive state the Ra, calculated from Steele's (40) steady state equation, was equal to the endogenous glucose production rate (EGPR), since there was no exogenous glucose infusion. During the clamp, the EGPR equaled the difference between the exogenous glucose infusion rate and the Ra calculated using Steele's (40) non-steady state equations (EGPR equals Ra minus exogenous glucose infusion rate). An effective volume of distribution of glucose of 100 ml/kg was assumed. The coefficient of variation of glucose specific activity during the clamp was calculated on each individual. The mean CV for all 18 subjects was 6.8±1.4%. When the Ra equaled the exogenous glucose infusion rate, the EGPR is assumed to be completely suppressed, so that the total glucose disposal rate equals the exogenous glucose infusion rate. The insulin-mediated glucose disposal, as we have described it, was in part due to glucose uptake in noninsulin-dependent tissues as well as that in insulin-dependent tissues. We use the term here in the limited sense, therefore, of glucose disposal during hyperinsulinaemia. These data were calculated for each 20-min period between 60 and 100 min during the clamp, and then averaged to calculate the total glucose disposal, or M value. Rate of turnover of FFA was calculated assuming a steady state as (26) (infusion rate [dpm/min])/(specific activity [dpm/,umol] Figs. 3 and 4) . During insulin administration, lipid oxidation fell and carbohydrate oxidation rose. The decrease in lipid oxidation correlated with the increase in carbohydrate oxidation (r = 0.96, P < 0.0001) (Fig. 4) . During the clamp, as in the basal state, the lipid oxidation negatively correlated with the carbohydrate oxidation (Fig. 3) .
Both clamp lipid and carbohydrate oxidation were correlated with the basal plasma FFA, and FFA turnover, basal lipid oxidation and basal carbohydrate oxidation rates (Table II) .
M value (Table II, Fig. 5 ). During the insulin administration the M value was significantly correlated with the glucose oxidation rate. The difference between these two measures, the nonoxidative glucose disposal (storage), also correlated with the M value. The relationship between these three measures is represented in Fig. 5 . In four individuals, glucose oxidation actually exceeded the M value, giving negative storage rates. The ratio of oxidation to total glucose uptake expressed as a percentage, therefore, ranged from 59 to 125%. The ratio of storage to oxidation increased with increasing M value (r = 0.69, P < 0.002).
The ). These were both correlated with the M value (r = 0.54, P < 0.02, and r = 0.82, P < 0.0001, respectively).
Effect of obesity (Table II) . The M value, clamp glucose oxidation, and clamp glucose storage were negatively correlated with obesity expressed as percent body fat (fat mass/total weight) or body mass index (BMI) (27, 42, 43) , and liver ketogenesis (44) . In discussing that energy balance is confined to much narrower limits than metabolism of FFAs it should be noted that FFA metabis the oxidation of carbohydrate or lipid. This presumably n includes the production and oxidation of ketones-the reflects some form of regulatory mechanism in energy metabke of ketones being proportional to their availability (4, (16), using similar techniques but with the addition of lipid infusions, several of their study groups had similar glucose oxidation rates but differing glucose uptake rates. In an in vitro study reported by Maizels et al. (9), glucose uptake and oxidation was compared in isolated soleus muscle. Addition of insulin and acetoacetate increased glucose uptake and lactate production but did not change glucose oxidation. These latter two studies were not analyzed with the particular questions we are raising in mind, however, so caution needs to be exercised in making these interpretations. It is also interesting to note several reports which demonstrated that the lactate production across a limb is well correlated with the FFA uptake or ketone availability (43, 45) . These latter reports are consistent with the hypothesis that stimulation of glycolysis under circumstances of increased FFA uptake or metabolism could result in lactate production rather than CO2 production from glucose.
In a study reported by Wolfe et al. (58) , the infusion of glucose or glucose plus insulin failed to increase total glucose oxidation or to decrease the lipid oxidation rate, as evidenced by a lack of change in total V02, VCO2, and RQ. There was, however, a progressive increase in the contribution of the labeled exogenous glucose load to the expired CO2 as the glucose uptake increased. The alteration of the relative contributions of exogenous and endogenous glucose to the total carbohydrate oxidation with increasing glucose loads has also been demonstrated by Mosora et al. (59) in somewhat differently designed studies. Both these studies suggest that under some circumstances the size of a glucose load will determine how much of the body's glucose stores will be oxidized or spared after a glucose load rather than how great the total glucose oxidation rate will be.
On the basis of the known effect of FFAs or ketones on glucose oxidation, we suggest, therefore, that the effect of insulin on glucose oxidation cannot be simply due to increased glucose uptake. Nevertheless, the effects of glucose uptake on the suppression of lipolysis and the stimulation of glycolysis and pyruvate oxidation might further increase both the fall in FFA concentrations and the consequent activation of pyruvate dehydrogenase brought about by insulin. Mechanism (b) (above), therefore, appears to best explain the known physiology, but a contribution of mechanism (a) cannot be excluded.
Because of the nature of this study, causal conclusions cannot be drawn from the demonstrated correlations. On the basis of the literature already cited, however, our data are consistent with the following hypothesis: Basal FFA concentration, regulated by whatever mechanisms, regulates the basal lipid oxidation rate, which in turn regulates basal carbohydrate oxidation rates. During insulin administration, the interindividual differences in FFA availability persist, but plasma levels fall. This leads to a fall in the lipid oxidation rates, which in turn allows carbohydrate oxidation rates to rise. Insulin's effect on glucose oxidation under this hypothesis would be indirect, as suggested by others (2, 3) , or at best partially indirect (via FFA regulation), and partially permissive/regulatory (by increasing intracellular availability of glucose).
Insulin-mediated glucose disposal. Indirect calorimetry allowed carbohydrate oxidation during the clamp to be measured simultaneously with the glucose uptake measurements. The difference between glucose oxidation and glucose disposalthe nonoxidative glucose disposal, is a measure of glucose storage (60, 61) . This measures, however, only the minimum glucose storage. It is quite possible that infused glucose could be stored while previously stored glycogen is oxidized, as suggested by studies comparing the rate of glucose oxidation from labeled glucose loads by measurement of expired labeled CO2 and the rate of glucose oxidation by indirect calorimetry (59, 62 and mechanisms of glucose storage rather than oxidation may provide important insights into the nature of impaired in vivo insulin action, and the metabolic impact of obesity on glucose metabolism.
Appendix
The purpose of the following discussion is to show that for RQ > 1.00, the absolute value of the calculated value of lipid oxidation is equivalent to lipid synthesis, and to show that for RQ > 1.00, the calculated value for carbohydrate oxidation overestimates the conversion of glucose to CO2 by the amount of glucose converted to lipid (and hence stored).
The Lusk equations can be used to calculate the relative distribution of oxygen between lipid and carbohydrate oxidation. When the RQ exceeds 1.00, however, the methods for calculating lipid synthesis and glucose conversion to lipid or CO2 are not as clear. The following is an explanation of the calculations we have used. They are not affected by the fact that lipid oxidation and synthesis may continue together, i.e., they only assume the net reaction. Furthermore, these equations cannot be used to determine the stoichiometry or RQ of lipid synthesis.
This discussion deals only with nonprotein oxidation, i.e., the RQ used here is the nonprotein RQ.
The following discussion does assume that if glucose is oxidized to CO2 or if glucose is first converted to lipid and then fully oxidized to CO2, that the total CO2 produced and 02 consumed will be the same, i.e., that the end products of glucose oxidation are independent of the mechanism of the reaction. Hydrogen and water have been left out of the following equations for the sake of simplicity, but it is assumed that the production of water would also be the same whichever pathway glucose followed in its oxidation. Excess CO2 is defined as the difference between the total CO2 produced in moles and the total 02 consumed in moles (excess C02). Excess 02 is similarly defined.
In moles:
(1) (2) (2a) (5) (6) (RQL) X (e) = (f).
RQL is a constant for any given lipid and (e) is a constant for any given (z).
In 
(9a)
( 1 1 (14) It can be seen that these equations are in the same form as the standard Lusk equations (42) . Lipid oxidized = (-1) X lipid synthesized. Calculation of oxidation rates merely requires the use of appropriate constants in Eqs. 13 
